MINTER Trial: Metal Intervention aNd ThErapy With Radiotherapy In Thoracic Cancer Using Copper Donor Therapy: A Phase 2, Open-Label Study
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT07843537
- Phase
- PHASE2
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Thoracic Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Disulfiram 250 mg — DRUGGiven orally once daily
- Copper Gluconate 2 mg — DRUGGiven orally three times daily
- Radiation Therapy — DRUGDelivered per institutional standards (radiotherapy alone in 10-15 fractions as local consolidation therapy).
Study Details
This study is being done to test whether adding two drugs-disulfiram and copper gluconate-to radiation therapy can help overcome this resistance and improve treatment outcomes. When disulfiram is combined with copper, it forms a substance that may increase stress within cancer cells and lead to a specific type of cancer cell death knowns as "cuproptosis".
Key Dates
- First listed
- Sep 28, 2026
- Start date
- Mar 1, 2027
- Status verified
- Sep 2026
- Primary completion
- Mar 30, 2030
- Completion
- Mar 30, 2032
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment with Disulfiram + Copper Gluconate + Concurrent LCT
Primary Outcome Measure
Safety and Adverse Events (AEs) [ Time Frame: Through study completion; an average of 1 year ]
Central Contacts
- Steven Lin, MD, PHD(713) 563-8490
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UT MD Anderson | Houston | Texas | 77030 | Steven Lin, MD, PHD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By research site
Related Studies
- Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC PatientsPHASE1/PHASE2 · Recruiting · Tango Therapeutics, Inc. · Scottsdale, Arizona
- Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)PHASE1 · Recruiting · University of Texas Southwestern Medical Center · Dallas, Texas
- Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated TumorsRecruiting · The New York Proton Center · New York, New York
- SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)Recruiting · Nadine Jackson, MD, MPH · Boston, Massachusetts